HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vanessa Barbaro Selected Research

Ectrodactyly-cleft lip-palate syndrome

1/2023Innovative Therapeutic Approaches for the Treatment of the Ocular Morbidities in Patients with EEC Syndrome.
8/2016Personalized Stem Cell Therapy to Correct Corneal Defects Due to a Unique Homozygous-Heterozygous Mosaicism of Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.
1/2016Correction of Mutant p63 in EEC Syndrome Using siRNA Mediated Allele-Specific Silencing Restores Defective Stem Cell Function.
1/2012Limbal stem cell deficiency and ocular phenotype in ectrodactyly-ectodermal dysplasia-clefting syndrome caused by p63 mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vanessa Barbaro Research Topics

Disease

4Ectrodactyly-cleft lip-palate syndrome
01/2023 - 01/2012
3Limbal Stem Cell Deficiency
05/2017 - 07/2010
2Retinitis Pigmentosa (Pigmentary Retinopathy)
03/2017 - 12/2016
2Ectodermal Dysplasia (Aplasia Cutis Congenita)
08/2016 - 01/2012
2Ectrodactyly
08/2016 - 01/2012
1Wounds and Injuries (Trauma)
01/2023
1Pterygium
11/2022
1Glaucoma
11/2022
1Cicatrix (Scar)
11/2022
1Macular Degeneration (Age-Related Maculopathy)
01/2022
1Fuchs' Endothelial Dystrophy
10/2021
1Conjunctival Diseases
04/2019
1Inflammation (Inflammations)
05/2017
1Drug-Related Side Effects and Adverse Reactions
05/2017
1Retinitis Pigmentosa 2
03/2017
1Myopia
12/2016
1Blindness (Hysterical Blindness)
01/2016
1Inborn Genetic Diseases (Disease, Hereditary)
06/2012
1Pain (Aches)
04/2012
1Photophobia (Light Sensitivity)
04/2012
1Vision Disorders (Hemeralopia)
08/2010
1Hereditary Corneal Dystrophies
08/2010

Drug/Important Bio-Agent (IBA)

2Transcription Factors (Transcription Factor)IBA
01/2023 - 01/2012
2GTP Phosphohydrolases (GTPases)IBA
03/2017 - 12/2016
1Trypan BlueFDA Link
01/2023
1Coloring Agents (Dyes)IBA
01/2023
1FibrinIBA
05/2017
1Small Interfering RNA (siRNA)IBA
01/2016
1Retinaldehyde (Retinal)IBA
06/2012
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
04/2012
1Keratins (Keratin)IBA
04/2012
1DNA (Deoxyribonucleic Acid)IBA
01/2012
1Keratan SulfateIBA
08/2010
1Carbohydrate SulfotransferasesIBA
08/2010
1Proteoglycans (Proteoglycan)IBA
08/2010
1Therapeutic UsesIBA
07/2010

Therapy/Procedure

3Transplantation
11/2022 - 05/2017
3Therapeutics
04/2019 - 01/2016
2Corneal Transplantation (Keratoplasty)
10/2021 - 04/2012
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2023
1Drug Therapy (Chemotherapy)
01/2023
1Filtering Surgery
11/2022
1Slit Lamp
01/2012